JP2022525102A5 - - Google Patents

Info

Publication number
JP2022525102A5
JP2022525102A5 JP2021554692A JP2021554692A JP2022525102A5 JP 2022525102 A5 JP2022525102 A5 JP 2022525102A5 JP 2021554692 A JP2021554692 A JP 2021554692A JP 2021554692 A JP2021554692 A JP 2021554692A JP 2022525102 A5 JP2022525102 A5 JP 2022525102A5
Authority
JP
Japan
Prior art keywords
radiation
peaks
necessary
xrpd pattern
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021554692A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525102A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/022221 external-priority patent/WO2020185983A1/en
Publication of JP2022525102A publication Critical patent/JP2022525102A/ja
Publication of JP2022525102A5 publication Critical patent/JP2022525102A5/ja
Pending legal-status Critical Current

Links

JP2021554692A 2019-03-12 2020-03-12 心臓トロポニン活性化因子の多形 Pending JP2022525102A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962817194P 2019-03-12 2019-03-12
US62/817,194 2019-03-12
PCT/US2020/022221 WO2020185983A1 (en) 2019-03-12 2020-03-12 Polymorphs of a cardiac troponin activator

Publications (2)

Publication Number Publication Date
JP2022525102A JP2022525102A (ja) 2022-05-11
JP2022525102A5 true JP2022525102A5 (cg-RX-API-DMAC7.html) 2023-03-22

Family

ID=70190163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021554692A Pending JP2022525102A (ja) 2019-03-12 2020-03-12 心臓トロポニン活性化因子の多形

Country Status (6)

Country Link
US (1) US20220185791A1 (cg-RX-API-DMAC7.html)
EP (1) EP3938042A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022525102A (cg-RX-API-DMAC7.html)
CN (1) CN114025845A (cg-RX-API-DMAC7.html)
TW (1) TWI857027B (cg-RX-API-DMAC7.html)
WO (1) WO2020185983A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004800A2 (pt) 2017-09-13 2020-09-24 Amgen Inc. compostos de bisamida ativantes do sarcômero e seus usos
SG11202109891WA (en) 2019-03-12 2021-10-28 Amgen Inc Polymorphs and cocrystals of a cardiac troponin activator
EP4308095A4 (en) 2021-03-15 2025-02-19 Maze Therapeutics, Inc. GLYCOGEN SYNTHASE 1 (GYS1) INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU3192500A (en) * 1999-03-16 2000-10-04 C & C Research Laboratories Substituted proline derivatives and medicinal compositions containing the same
TW200911787A (en) * 2007-07-03 2009-03-16 Astrazeneca Ab New aza-bicyclohexane compounds useful as inhibitors of thrombin
EP3821882A1 (en) * 2013-03-14 2021-05-19 Amgen Inc. Heterocyclic compounds and their uses
BR112020004800A2 (pt) * 2017-09-13 2020-09-24 Amgen Inc. compostos de bisamida ativantes do sarcômero e seus usos

Similar Documents

Publication Publication Date Title
TWI660956B (zh) 調節蛋白質激酶之化合物的合成
AU2014239995B2 (en) Salt of omecamtiv mecarbil and process for preparing salt
JP2018504429A5 (cg-RX-API-DMAC7.html)
JP2018520205A (ja) レンバチニブメシル酸塩の新規結晶形及びその製造方法
JP6830888B2 (ja) Jak阻害剤の硫酸水素塩の結晶形およびその製造方法
TW200529850A (en) Methods of preparing aripiprazole crystalline forms
JP2021518400A5 (cg-RX-API-DMAC7.html)
JP2018501289A (ja) ネラチニブマレイン酸塩の新規な結晶形及びその製造方法
JP2012526808A5 (cg-RX-API-DMAC7.html)
US10947225B2 (en) Phosphotidylinositol 3-kinase inhibitors
KR102576930B1 (ko) 제2철 말톨의 결정질 형태
CN102232070A (zh) (r)-5-((e)-2-(吡咯烷-3-基乙烯基)嘧啶的合成和新的盐形式
JP2023521411A5 (cg-RX-API-DMAC7.html)
RU2011101661A (ru) Пиримидилсульфонамидное производное и его применение для лечения хемокин-опосредованных заболеваний
JP2011528030A5 (cg-RX-API-DMAC7.html)
US8785663B2 (en) Polymorphic forms of Lubiprostone
CA3095922A1 (en) Solid-state forms of abemaciclib, their use and preparation
JP2024530315A (ja) Bcl-2阻害剤の固体形態、それらの調製方法及び使用方法
JP2024509276A5 (cg-RX-API-DMAC7.html)
JP2020503330A5 (cg-RX-API-DMAC7.html)
JP2017507914A (ja) テノホビルの固体形態
JP2019504046A (ja) チエノピリミジン化合物の結晶形
JP2025533955A (ja) (2s,5r)-5-(2-クロロフェニル)-1-(2’-メトキシ-[1,1’-ビフェニル]-4-カルボニル)ピロリジン-2-カルボン酸の多形およびその調製プロセス
RU2019114208A (ru) Кристаллические формы 4-(2-((1r,2r)-2-гидроксициклогексиламино)бензотиазол-6-илокси)-n-метилпиколинамида
JP2024529533A5 (cg-RX-API-DMAC7.html)